Vanda Pharmaceuticals
$12.069876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.
$12.06
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
-$1.36 (-10.13%) As of 2:34 PM EST today
-$1.36 (-10.13%) Today
Why Robinhood?
You can buy or sell VNDA and other stocks, options, ETFs, and crypto commission-free!
About VNDA
Vanda Pharmaceuticals, Inc. engages in the development and commercialization of therapies for high unmet medical needs. It intends to treat schizophrenia, jet lag disorder, atopic dermatitis, central nervous system disorders, and circadian rhythm sleep disorder. Read More Its product portfolio includes HETLIOZ, Fanapt, Tradipitant, Trichostatin, and AQW051. The company was founded by Mihael Hristos Polymeropoulos and Argeris N. Karabelas in 2002 and is headquartered in Washington, DC.
Employees
270
Headquarters
Washington, District of Columbia
Founded
2002
Market Cap
677.38M
Price-Earnings Ratio
6.00
Dividend Yield
—
Average Volume
365.96K
High Today
$13.39
Low Today
$12.01
Open Price
$13.38
Volume
704.53K
52 Week High
$21.41
52 Week Low
$11.83
Collections
VNDA Earnings
-$0.18
-$0.03
$0.13
$0.28
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Q3 2019
Q4 2019
Estimated
— per share
Actual
Available Feb 25, After Hours
People Also Bought
Canopy Growth
178,857
$21.86
-2.02%Aphria
99,573
$4.15
-2.70%Cronos Group
192,183
$7.16
-2.44%Aurora Cannabis
671,428
$1.65
-1.49%Tilray
43,873
$19.32
+0.42%Hexo
166,615
$1.42
-1.46%Viking Therapeutics
38,964
$6.88
-1.22%Corbus Pharmaceuticals
49,073
$5.57
-1.85%NIO
127,918
$4.03
-5.40%GameStop
19,799
$4.06
-1.93%Verastem
17,519
$2.18
+3.81%CannTrust
103,242